Long-acting insulin analogues in type 1 diabetes: No proof of additional benefit
Links shared publicly online about this topic.
- 1,174total visits
Long-acting insulin analogues in type 1 diabetes: No proof of additional benefit
View full resource at physorg.com
Tags: Diabetes, Diabetes Type 1 Medication, Diabetes Type 2 Medication, Diabetes Medication, Insulin, Type 1 Diabetes, Lantus
Most Recently Shared on May 12, 2010 at 1:56 pm By:
Long-acting insulin analogues in type 1 diabetes: No proof of additional benefit http://tw.physorg.com/192876972
Long-acting insulin analogues in type 1 diabetes: No proof of additional benefit | ScienceBlog.com
scienceblog.com — “Long-acting insulin analogues in type 1 diabetes: No proof of additional benefit | ScienceBlog.com” View full resource at scienceblog.com
Most Recently Shared on May 12, 2010 at 3:20 pm By:
Scott Strumello Patient Expert
ScienceBlog.com - "Long-acting insulin analogues in type 1 diabetes: No proof of additional benefit" http://bit.ly/cN1U5y
Rapid-Acting Insulin Analogues: Trials Provide No Proof Of Additional Benefit For Children And Adolescents With Type 1 Diabetes
medicalnewstoday.com — “Long-term research is lacking - potential harm remains unclear - valid studies are urgently needed for growing and developing children and adolescentsDue to a lack of suitable stu” View full resource at medicalnewstoday.com
Most Recently Shared on December 21, 2009 at 1:07 pm By:
MNT Clinical Trials Health News
Rapid-Acting Insulin Analogues: Trials Provide No Proof Of Additional Benefit For Children And Adolescents With Type 1... http://mnt.to/3vK2
Advertisement
